Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.3 has been added to the page history, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed from the list.SummaryDifference0.0%

- Check40 days agoChange DetectedNew revision entry v3.4.1 appears in the version history, and a 'Study Status' section is listed under additions. The previous revision v3.4.0 is shown as a deletion.SummaryDifference0.2%

- Check47 days agoChange DetectedNew UI elements include Show glossary and Hide glossary options and a legend for green highlights (additions) and red highlights (deletions), plus a color-coded note explaining changes. The revision label now reads Revision: v3.4.0, replacing v3.3.4.SummaryDifference0.4%

- Check61 days agoChange DetectedFooter now displays Revision: v3.3.4 instead of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedVersion 2025-12-19 adds/updates the 'Study Status' entry in the record history for NCT01946204 (Revision: v3.3.3). The 'HHS Vulnerability Disclosure' link is removed in Revision: v3.3.2.SummaryDifference0.2%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.